-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 FM6SlrlEh9iSygCgrzwQNYIbU11QEcSvQdY2JfFynb+aaVti3ruSclcp3ZWiRhjS
 77Mzu9fr/6MememTet+g6w==

<SEC-DOCUMENT>0000012208-05-000024.txt : 20050804
<SEC-HEADER>0000012208-05-000024.hdr.sgml : 20050804
<ACCEPTANCE-DATETIME>20050804162348
ACCESSION NUMBER:		0000012208-05-000024
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20050630
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20050804
DATE AS OF CHANGE:		20050804

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIO RAD LABORATORIES INC
		CENTRAL INDEX KEY:			0000012208
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				941381833
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-07928
		FILM NUMBER:		05999702

	BUSINESS ADDRESS:	
		STREET 1:		1000 ALFRED NOBEL DR
		CITY:			HERCULES
		STATE:			CA
		ZIP:			94547
		BUSINESS PHONE:		5107247000
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>f8k.htm
<TEXT>
<!doctype html public "-//IETF//DTD HTML//EN">
<HTML>
<HEAD>
<TITLE>Bio-Rad Laboratories, Inc</TITLE>
<META NAME="author" CONTENT="Stephanie Trudrung">
<META NAME="date" CONTENT="08/04/2005">
</HEAD>
<BODY style="line-height:12pt; font-size:10pt; color:#000000">
<P style="margin:0pt; line-height:13pt; font-family:Arial; font-size:11pt" align=center>UNITED STATES</P>
<P style="margin:0pt; line-height:13pt; font-family:Arial; font-size:11pt" align=center>SECURITIES AND EXCHANGE COMMISSION</P>
<P style="margin:0pt; line-height:13pt; font-family:Arial; font-size:11pt" align=center>Washington, D.C. &nbsp;20549</P>
<P style="margin:0pt; font-family:Arial; font-size:11pt" align=center><BR></P>
<P style="margin:0pt; line-height:13pt; font-family:Arial; font-size:11pt" align=center>Form 8-K</P>
<P style="margin:0pt; font-family:Arial; font-size:11pt" align=center><BR></P>
<P style="margin:0pt; line-height:13pt; font-family:Arial; font-size:11pt" align=center>CURRENT REPORT</P>
<P style="margin:0pt; line-height:13pt; font-family:Arial; font-size:11pt" align=center>PURSUANT TO SECTION 13 OR 15(D)OF THE SECURITIES EXCHANGE ACT OF 1934</P>
<P style="margin:0pt; font-family:Arial; font-size:11pt" align=center><BR></P>
<TABLE style="font-size:10pt" cellspacing=0><TR><TD valign=top width=643.2>&nbsp;</TD></TR>
<TR><TD valign=top width=643.2>&nbsp;</TD></TR>
<TR><TD style="border-bottom:0.5pt solid #000000" valign=top width=643.2><P style="margin:0pt; line-height:13pt; font-family:Arial; font-size:11pt" align=center>Date of Report: June 30, 2005</P>
</TD></TR>
<TR><TD valign=top width=643.2><P style="margin:0pt; font-family:Arial" align=center>(Date of earliest event reported)</P>
</TD></TR>
</TABLE>
<P style="margin:0pt; font-family:Arial; font-size:11pt" align=center><BR></P>
<TABLE style="font-size:10pt" cellspacing=0><TR><TD valign=top width=48>&nbsp;</TD><TD valign=top width=588><P style="margin:0pt; line-height:13pt; font-family:Arial; font-size:11pt" align=center>BIO-RAD LABORATORIES, INC.</P>
</TD></TR>
</TABLE>
<P style="margin:0pt; padding-left:36pt; line-height:13pt; font-family:Arial; font-size:11pt" align=center>(Exact name of registrant as specified in its charter)</P>
<P style="margin:0pt; padding-left:36pt; font-family:Arial; font-size:11pt" align=center><BR></P>
<P style="margin:0pt; padding-left:14.4pt; line-height:13pt; font-family:Arial; font-size:11pt" align=center>Commission file number <U>1-7928</U></P>
<P style="margin:0pt; padding-left:36pt; font-family:Arial; font-size:11pt" align=center><BR></P>
<TABLE style="font-size:10pt" cellspacing=0><TR><TD style="border-bottom:0.5pt solid #000000" valign=top width=367.267><P style="margin:0pt; line-height:13pt; font-family:Arial; font-size:11pt" align=center>Delaware</P>
</TD><TD style="border-bottom:0.5pt solid #000000" valign=top width=17.533>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" valign=top width=268.133 colspan=2><P style="margin:0pt; font-family:Arial; font-size:11pt" align=center>94-1381833</P>
</TD></TR>
<TR><TD valign=top width=367.267><P style="margin:0pt; font-family:Arial" align=center>(State or other jurisdiction of incorporation or organization)</P>
</TD><TD valign=top width=17.533>&nbsp;</TD><TD valign=top width=268.133 colspan=2><P style="margin:0pt; font-family:Arial" align=center>(I.R.S. Employer Identification No.)</P>
</TD></TR>
<TR><TD valign=top width=367.267>&nbsp;</TD><TD valign=top width=17.533>&nbsp;</TD><TD valign=top width=268.133 colspan=2>&nbsp;</TD></TR>
<TR><TD style="border-bottom:0.5pt solid #000000" valign=top width=367.267><P style="margin:0pt; font-family:Arial; font-size:11pt" align=center>1000 Alfred Nobel Drive, Hercules, California</P>
</TD><TD style="border-bottom:0.5pt solid #000000" valign=top width=17.533>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" valign=top width=268.133 colspan=2><P style="margin:0pt; font-family:Arial; font-size:11pt" align=center>94547</P>
</TD></TR>
<TR><TD valign=top width=384.8 colspan=2><P style="margin:0pt; font-family:Arial" align=center>(Address of principal executive offices)</P>
</TD><TD valign=top width=19.2>&nbsp;</TD><TD valign=top width=248.933><P style="margin:0pt; font-family:Arial" align=center>(Zip Code)</P>
</TD></TR>
<TR><TD valign=top width=652.933 colspan=4>&nbsp;</TD></TR>
<TR><TD style="border-bottom:0.5pt solid #000000" valign=top width=652.933 colspan=4><P style="margin:0pt; font-family:Arial; font-size:11pt" align=center>(510)724-7000</P>
</TD></TR>
<TR><TD valign=top width=652.933 colspan=4><P style="margin:0pt; font-family:Arial" align=center>Registrant's telephone number, including area code</P>
</TD></TR>
<TR><TD valign=top width=652.933 colspan=4>&nbsp;</TD></TR>
<TR><TD valign=top width=652.933 colspan=4>&nbsp;</TD></TR>
<TR><TD valign=top width=652.933 colspan=4><P style="margin-top:0pt; margin-bottom:-14pt; line-height:14pt; font-family:Arial; font-size:11pt">ITEM 2.02 .</P>
<P style="margin:0pt; text-indent:72pt; font-family:Arial; font-size:11pt">RESULTS OF OPERATIONS AND FINANCIAL CONDITION.</P>
</TD></TR>
<TR><TD valign=top width=652.933 colspan=4>&nbsp;</TD></TR>
<TR><TD valign=top width=652.933 colspan=4><P style="margin:0pt; text-indent:36pt; font-family:Arial">The information in Item 2.02 of the Report, including Exhibit 99.1 attached hereto, is being furnished pursuant to Item 2.02 of Form 8-K. &nbsp;Consequently, it is not deemed &#147;filed&#148; for the purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. &nbsp;It may only be incorporate by reference in another filing under the Exchange Act or Securities Act of 1933, as amended, if such subsequent filing specifically references this Form 8-K. &nbsp;</P>
<P style="margin:0pt; font-family:Arial"><BR></P>
<P style="margin:0pt; text-indent:36pt; font-family:Arial">On August 4, Bio-Rad Laboratories, Inc. announced its results of operations and financial condition as of and for the second quarter ended June 30, 2005. &nbsp;A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.</P>
</TD></TR>
<TR><TD valign=top width=652.933 colspan=4>&nbsp;</TD></TR>
</TABLE>
<P style="margin:0pt; font-family:Courier New; font-size:12pt"><BR></P>
<P style="margin:0pt; font-family:Courier New; font-size:12pt"><BR>
<BR></P>
<P style="page-break-before:always; margin:0pt; font-family:Courier New; font-size:12pt"><BR></P>
<P style="margin-top:0pt; margin-bottom:-13pt; line-height:13pt; font-family:Arial; font-size:11pt">Item 9.01</P>
<P style="margin:0pt; text-indent:72pt; line-height:13pt; font-family:Arial; font-size:11pt">FINANCIAL STATEMENTS AND EXHIBITS</P>
<P style="margin:0pt; font-family:Arial; font-size:11pt"><BR></P>
<P style="margin:0pt; font-family:Arial; font-size:11pt"><BR></P>
<TABLE style="font-size:10pt" cellspacing=0><TR><TD valign=top width=91.2><P style="margin:0pt; line-height:13pt; font-family:Symbol; font-size:11pt">(<FONT FACE="Arial">c</FONT>)</P>
</TD><TD valign=top width=528><P style="margin:0pt; line-height:13pt; font-family:Arial; font-size:11pt">Exhibits</P>
</TD></TR>
<TR><TD valign=top width=91.2>&nbsp;</TD><TD valign=top width=528>&nbsp;</TD></TR>
</TABLE>
<P style="margin:0pt; font-family:Arial; font-size:11pt"><BR></P>
<TABLE style="font-size:10pt" cellspacing=0><TR><TD valign=top width=91.2><P style="margin:0pt; line-height:13pt; font-family:Arial; font-size:11pt">Exhibit </P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=512.267>&nbsp;</TD></TR>
<TR><TD style="border-bottom:0.5pt solid #000000" valign=top width=91.2><P style="margin:0pt; line-height:13pt; font-family:Arial; font-size:11pt">Number</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" valign=top width=512.267><P style="margin:0pt; line-height:13pt; font-family:Arial; font-size:11pt">Description</P>
</TD></TR>
<TR><TD valign=top width=91.2><P style="margin:0pt; line-height:13pt; font-family:Arial; font-size:11pt">99.1</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=512.267><P style="margin:0pt; line-height:13pt; font-family:Arial; font-size:11pt">Press Release for second quarter financial results of</P>
</TD></TR>
<TR><TD valign=top width=91.2>&nbsp;</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=512.267><P style="margin:0pt; line-height:13pt; font-family:Arial; font-size:11pt">Bio-Rad Laboratories, Inc., dated August 4, 2005. &nbsp;This exhibit is</P>
</TD></TR>
<TR><TD valign=top width=91.2>&nbsp;</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=512.267><P style="margin:0pt; line-height:13pt; font-family:Arial; font-size:11pt">being furnished pursuant to Item 2.02 of Form 8-K</P>
</TD></TR>
</TABLE>
<P style="margin:0pt; font-family:Arial; font-size:11pt"><BR></P>
<P style="margin:0pt; font-family:Arial; font-size:11pt"><BR></P>
<P style="margin:0pt; font-family:Arial; font-size:11pt"><BR></P>
<P style="margin:0pt; font-family:Arial; font-size:11pt"><BR></P>
<P style="margin:0pt; line-height:13pt; font-family:Arial; font-size:11pt" align=center>SIGNATURES</P>
<P style="margin:0pt; font-family:Arial; font-size:11pt" align=center><BR></P>
<P style="margin:0pt; line-height:13pt; font-family:Arial; font-size:11pt">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>
<P style="margin:0pt; font-family:Arial; font-size:11pt"><BR></P>
<TABLE style="font-size:10pt" cellspacing=0 align=center><TR><TD valign=top width=163.2>&nbsp;</TD><TD valign=top width=252><P style="margin:0pt; line-height:13pt; font-family:Arial; font-size:11pt">BIO-RAD LABORATORIES, INC.</P>
</TD></TR>
<TR><TD valign=top width=163.2>&nbsp;</TD><TD valign=top width=252>&nbsp;</TD></TR>
<TR><TD valign=top width=163.2>&nbsp;</TD><TD valign=top width=252>&nbsp;</TD></TR>
<TR><TD valign=top width=163.2><P style="margin:0pt; line-height:13pt; font-family:Arial; font-size:11pt">Date: &nbsp;August 4, 2005</P>
</TD><TD style="border-bottom:0.5pt solid #000000" valign=top width=252><P style="margin:0pt; line-height:13pt; font-family:Arial; font-size:11pt">/s/ Christine A. Tsingos</P>
</TD></TR>
<TR><TD valign=top width=163.2>&nbsp;</TD><TD valign=top width=252><P style="margin:0pt; line-height:13pt; font-family:Arial; font-size:11pt">Christine A. Tsingos, </P>
</TD></TR>
<TR><TD valign=top width=163.2>&nbsp;</TD><TD valign=top width=252><P style="margin:0pt; line-height:13pt; font-family:Arial; font-size:11pt">Chief Financial Officer</P>
</TD></TR>
</TABLE>
<P style="margin:0pt; font-family:Arial; font-size:11pt"><BR></P>
<P style="margin:0pt; font-family:Arial; font-size:11pt"><BR></P>
<P style="margin:0pt; font-family:Arial; font-size:11pt"><BR></P>
<P style="margin:0pt; line-height:13pt; font-family:Arial; font-size:11pt" align=center>EXHIBIT INDEX</P>
<P style="margin:0pt; font-family:Arial; font-size:11pt" align=center><BR></P>
<P style="margin:0pt; font-family:Arial; font-size:11pt" align=center><BR></P>
<TABLE style="font-size:10pt" cellspacing=0><TR><TD valign=top width=91.2><P style="margin:0pt; line-height:13pt; font-family:Arial; font-size:11pt">Exhibit </P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=512.267>&nbsp;</TD></TR>
<TR><TD style="border-bottom:0.5pt solid #000000" valign=top width=91.2><P style="margin:0pt; line-height:13pt; font-family:Arial; font-size:11pt">Number</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" valign=top width=512.267><P style="margin:0pt; line-height:13pt; font-family:Arial; font-size:11pt">Description</P>
</TD></TR>
<TR><TD valign=top width=91.2><P style="margin:0pt; line-height:13pt; font-family:Arial; font-size:11pt">99.1</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=512.267><P style="margin:0pt; line-height:13pt; font-family:Arial; font-size:11pt">Press Release for second quarter financial results of</P>
</TD></TR>
<TR><TD valign=top width=91.2>&nbsp;</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=512.267><P style="margin:0pt; line-height:13pt; font-family:Arial; font-size:11pt">Bio-Rad Laboratories, Inc., dated August 4, 2005. &nbsp;This exhibit is</P>
</TD></TR>
<TR><TD valign=top width=91.2>&nbsp;</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=512.267><P style="margin:0pt; line-height:13pt; font-family:Arial; font-size:11pt">being furnished pursuant to Item 2.02 of Form 8-K</P>
</TD></TR>
</TABLE>
<P style="margin:0pt; font-family:Arial; font-size:12pt"><BR></P>
<P style="margin:0pt; font-family:Arial; font-size:12pt"><BR>
<BR></P>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1 CHARTER
<SEQUENCE>2
<FILENAME>exh991.htm
<TEXT>
<!doctype html public "-//IETF//DTD HTML//EN">
<HTML>
<HEAD>
<TITLE>Exhibit 99</TITLE>
<META NAME="author" CONTENT="Stephanie Trudrung">
<META NAME="date" CONTENT="08/04/2005">
</HEAD>
<BODY style="line-height:12pt; font-size:10pt; color:#000000">
<P style="margin:0pt; line-height:17pt; font-family:Arial" align=right><B>Exhibit 99.1</B></P>
<P style="margin:0pt; line-height:14pt; font-family:Arial; font-size:8pt"><I>FOR IMMEDIATE RELEASE</I></P>
<P style="margin:0pt; line-height:18.5pt; font-family:Arial; font-size:11pt" align=center>Bio-Rad Reports Second Quarter Financial Results</P>
<P style="margin:0pt; line-height:16pt; font-family:Arial">HERCULES, CA &#150; August 4, 2005 &#150; Bio-Rad Laboratories, Inc. (AMEX: BIO and BIOb), a multinational manufacturer and distributor of life science research products and clinical diagnostics, announced financial results today for the second quarter ended June 30, 2005. Second-quarter net sales from continuing operations were $291.3 million, up 11.8 percent compared to the $260.5 million reported for the second quarter of 2004, while sales were up by 8.5 percent on a currency neutral basis for the same period. This increase was the result of strong sales in the areas of diabetes monitoring, blood virus screening, quality controls, protein expression analysis and amplification products (due in part to the acquisition of MJ Research). While overall profit margins were down slightly due to the declining average selling price of BSE tests and real time PCR instrumentation, Bio-Rad continues to retain significant market share of the BSE business worldw
ide and has now resumed the sale of real time PCR products in Japan, following a ruling by the Japanese patent authority invalidating Applera&#146;s patent. Second quarter income from continuing operations was $18.4 million, or $0.71 per share, down 9.3 percent from the same period last year, due to the company&#146;s continuing investment in systems and infrastructure and increased interest expense associated with the sale of bonds in December 2004.</P>
<P style="margin:0pt; line-height:16pt; font-family:Arial"><BR></P>
<P style="margin:0pt; line-height:16pt; font-family:Arial">Net sales for the first half of the year increased by 12.8 percent to $590.5 million compared to the $523.3 million reported in the same period of 2004. Income from continuing operations increased by 11.7 percent to $47.9 million, or $1.85 per share, compared to $42.9 million, or $1.67 per share, for the first six months of 2004. Year-over-year net sales for the Life Science segment increased by 17.7 percent to $277.2 million, compared to the $235.5 million reported June 30, 2004; Clinical Diagnostics net sales also increased to $307.2, up 8.4 percent from the $283.3 million reported for the first six months of 2004. &nbsp;&nbsp;</P>
<P style="margin:0pt; line-height:16pt; font-family:Arial"><BR></P>
<P style="margin:0pt; line-height:16pt; font-family:Arial">Second-Quarter Highlights</P>
<P style="margin-top:0pt; margin-bottom:-18pt; padding-left:18pt; text-indent:-18pt; line-height:18pt; font-family:Arial">-</P>
<P style="margin:0pt; padding-left:18pt; line-height:16pt; font-family:Arial">Net sales for the quarter increased by 11.8 percent to $291.3 million compared to $260.5 million reported in the second quarter of 2004.</P>
<P style="margin-top:0pt; margin-bottom:-18pt; padding-left:18pt; text-indent:-18pt; line-height:18pt; font-family:Arial">-</P>
<P style="margin:0pt; padding-left:18pt; line-height:16pt; font-family:Arial">Life Science segment net sales for the quarter were $133.1 million, up 16.9 percent over the same period last year, which includes a 3.2 percent increase due to currency effects. Sales of the Bio-Plex platform and protein expression analysis reagents used with this system continue to grow and sales of the new Experion<SUP>TM</SUP> automated electrophoresis system are also increasing significantly. </P>
<P style="margin-top:0pt; margin-bottom:-18pt; padding-left:18pt; text-indent:-18pt; line-height:18pt; font-family:Arial">-</P>
<P style="margin:0pt; padding-left:18pt; line-height:16pt; font-family:Arial">The Life Science segment introduced several new products during the second quarter which include the EXQuest proteomics robotics platform used in protein expression research to harvest samples from two-dimensional electrophoresis gels, and two real time amplification platforms, the iQ5 and the MiniOpticon, which is among the first generation of new products to come out of the acquisition of MJ Research. Integration of MJ continues to proceed as planned and Bio-Rad now operates direct selling and support channels in most regions. </P>
<P style="margin-top:0pt; margin-bottom:-18pt; padding-left:18pt; text-indent:-18pt; line-height:18pt; font-family:Arial">-</P>
<P style="margin:0pt; padding-left:18pt; line-height:16pt; font-family:Arial">Another significant event during the quarter was the official USDA confirmation of the first reported indigenous case of BSE in the United States in June. These results corroborate the initial findings of two </P>
<P style="margin:0pt; padding-left:18pt; text-indent:-18pt; line-height:16pt; font-family:Arial"><BR></P>
<P style="page-break-before:always; margin:0pt; padding-left:18pt; line-height:16pt; font-family:Arial">Bio-Rad BSE screening tests conducted on the suspect cow last November. The company&#146;s tests have been used to screen more than 400,000 cattle in the USDA&#146;s enhanced surveillance program.</P>
<P style="margin-top:0pt; margin-bottom:-18pt; padding-left:18pt; text-indent:-18pt; line-height:18pt; font-family:Arial">-</P>
<P style="margin:0pt; padding-left:18pt; line-height:16pt; font-family:Arial">Clinical Diagnostics segment net sales for the quarter were $155.2 million, an increase of 7.5 percent compared to the $144.4 million reported in the second quarter of 2004. A little less than half of this gain is the result of currency effects. Strong sales of blood virus screening products in the U.S. transfusion sector and expanding worldwide demand for the company&#146;s quality control products were the primary contributors to increased quarterly net sales. Other gains in the Clinical Diagnostics segment include increased sales of newborn screening products in Northern Europe and strong demand for the company&#146;s diabetes monitoring products in Asia Pacific.</P>
<P style="margin:0pt; line-height:16pt; font-family:Arial"><BR></P>
<P style="margin:0pt; line-height:16pt; font-family:Arial">&#147;At the halfway mark of 2005, it appears that the year is shaping up to be another one of progress on a number of fronts. Sales in many regions are meeting or exceeding expectations, new products are finding acceptance around the world and the outlook for the remainder of the year is positive,&#148; said President and Chief Executive Officer Norman Schwartz.</P>
<P style="margin:0pt; line-height:16pt; font-family:Arial"><BR></P>
<P style="margin:0pt; line-height:16pt; font-family:Arial">Management will discuss these results in a conference call scheduled for 2:00 p.m. PT (5:00 p.m. ET) today, August 4, 2005. Interested parties can access the call by dialing 866-271-6130 (in the U.S.), or 617-213-8894 (international), access number 76386582. The live web cast can be accessed at (&quot;http://www.bio-rad.com&quot;). A replay of the call will be available at 888-286-8010 (in the U.S.), or 617-801-6888 (international), access number 57744653 for seven days following the call and the web cast can be accessed at &quot;http://www.bio-rad.com&quot; for 30 days.</P>
<P style="margin:0pt; line-height:16pt; font-family:Arial"><BR></P>
<P style="margin:0pt; line-height:16pt; font-family:Arial">Bio-Rad Laboratories, Inc. (&quot;http://www.bio-rad.com&quot;) is a multinational manufacturer and distributor of life science research products and clinical diagnostics. It is based in Hercules, California, and serves thousands of research and industry customers worldwide through a network of more than 30 wholly owned subsidiary offices. </P>
<P style="margin:0pt; line-height:16pt; font-family:Arial"><BR></P>
<P style="margin:0pt; font-family:Arial"><I>Various statements made within this press release may constitute &#147;forward-looking statements&#148; for purposes of the Securities and Exchange Commission&#146;s &#147;safe harbor&#148; provisions under the Private Securities Litigation Reform Act of 1995 and Rule 3b-6 under the Securities Exchange Act of 1934. The forward-looking statements contained herein involve risks and uncertainties that could cause results to differ materially from the Company&#146;s expectations.</I></P>
<P style="margin:0pt; line-height:16pt; font-family:Arial"><BR></P>
<P style="margin:0pt; line-height:16pt; font-family:Arial">For more information, contact:<BR>
Christine Tsingos, Chief Financial Officer, or</P>
<P style="margin:0pt; line-height:16pt; font-family:Arial">Ron Hutton, Treasurer</P>
<P style="margin:0pt; line-height:16pt; font-family:Arial">Bio-Rad Laboratories, Inc.</P>
<P style="margin:0pt; line-height:16pt; font-family:Arial">Phone: &nbsp;(510) 724-7000<BR>
E-mail: investor_relations@bio-rad.com</P>
<P style="margin:0pt; line-height:16pt; font-family:Arial"><BR></P>
<P style="margin:0pt; line-height:16pt; font-family:Arial" align=center># # #</P>
<P style="margin:0pt; font-family:Arial; font-size:11pt"><BR>
<BR></P>
<P style="page-break-before:always; margin:0pt; font-family:Courier New; font-size:12pt"><BR></P>
<TABLE style="font-size:10pt" cellspacing=0><TR><TD valign=top width=650.467 colspan=8><P style="margin:0pt; font-family:Arial" align=center>BIO-RAD LABORATORIES, INC.</P>
</TD></TR>
<TR><TD valign=top width=650.467 colspan=8><P style="margin:0pt; font-family:Arial" align=center>Second Quarter 2005</P>
</TD></TR>
<TR><TD valign=top width=650.467 colspan=8><P style="margin:0pt; font-family:Arial" align=center>Condensed Consolidated Statements of Income</P>
</TD></TR>
<TR><TD valign=top width=650.467 colspan=8><P style="margin:0pt; font-family:Arial" align=center>(In thousands, except per share data)</P>
</TD></TR>
<TR><TD valign=top width=650.467 colspan=8><P style="margin:0pt; font-family:Arial" align=center>(Unaudited)</P>
</TD></TR>
<TR><TD valign=top width=320.8>&nbsp;</TD><TD valign=top width=156 colspan=3>&nbsp;</TD><TD valign=top width=12>&nbsp;</TD><TD valign=top width=161.667 colspan=3>&nbsp;</TD></TR>
<TR><TD valign=top width=320.8>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" valign=top width=156 colspan=3><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=center>Three Months Ended</P>
<P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=center>June 30,</P>
</TD><TD valign=top width=12>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" valign=top width=161.667 colspan=3><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=center>Six Months Ended</P>
<P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=center>June 30,</P>
</TD></TR>
<TR><TD width=320.8>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=center>2005</P>
</TD><TD width=12>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=center>2004</P>
</TD><TD width=12>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" width=78><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=center>2005</P>
</TD><TD width=12.4>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" width=71.267><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=center>2004</P>
</TD></TR>
<TR><TD width=320.8>&nbsp;</TD><TD width=72>&nbsp;</TD><TD width=12>&nbsp;</TD><TD width=72>&nbsp;</TD><TD width=12>&nbsp;</TD><TD width=78>&nbsp;</TD><TD width=12.4>&nbsp;</TD><TD width=71.267>&nbsp;</TD></TR>
<TR><TD width=320.8><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt">Net sales</P>
</TD><TD width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>$ &nbsp;&nbsp;291,302&nbsp;</P>
</TD><TD width=12>&nbsp;</TD><TD width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>$ &nbsp;260,546&nbsp;</P>
</TD><TD width=12>&nbsp;</TD><TD width=78><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>$ &nbsp;&nbsp;590,473</P>
</TD><TD width=12.4>&nbsp;</TD><TD width=71.267><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>$ &nbsp;523,295&nbsp;</P>
</TD></TR>
<TR><TD width=320.8><P style="margin:0pt; text-indent:14.4pt; line-height:11pt; font-family:Arial; font-size:9pt">Cost of good sold</P>
</TD><TD style="border-bottom:0.5pt solid #000000" width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>130,659&nbsp;</P>
</TD><TD width=12>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>110,885&nbsp;</P>
</TD><TD width=12>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" width=78><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>263,424</P>
</TD><TD width=12.4>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" width=71.267><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>224,370&nbsp;</P>
</TD></TR>
<TR><TD width=320.8><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt">Gross profit</P>
</TD><TD width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>160,643&nbsp;</P>
</TD><TD width=12>&nbsp;</TD><TD width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>149,661&nbsp;</P>
</TD><TD width=12>&nbsp;</TD><TD width=78><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>327,049</P>
</TD><TD width=12.4>&nbsp;</TD><TD width=71.267><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>298,925&nbsp;</P>
</TD></TR>
<TR><TD valign=bottom width=320.8>&nbsp;</TD><TD valign=bottom width=72>&nbsp;</TD><TD valign=bottom width=12>&nbsp;</TD><TD valign=bottom width=72>&nbsp;</TD><TD valign=bottom width=12>&nbsp;</TD><TD valign=bottom width=78>&nbsp;</TD><TD valign=bottom width=12.4>&nbsp;</TD><TD valign=bottom width=71.267>&nbsp;</TD></TR>
<TR><TD valign=bottom width=320.8><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt">Selling, general and administrative expense</P>
</TD><TD valign=bottom width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>104,222&nbsp;</P>
</TD><TD valign=bottom width=12>&nbsp;</TD><TD valign=bottom width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>90,199&nbsp;</P>
</TD><TD valign=bottom width=12>&nbsp;</TD><TD valign=bottom width=78><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>203,720</P>
</TD><TD valign=bottom width=12.4>&nbsp;</TD><TD valign=bottom width=71.267><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>177,256&nbsp;</P>
</TD></TR>
<TR><TD width=320.8><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt">Product research and development expense</P>
</TD><TD width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>28,499&nbsp;</P>
</TD><TD width=12>&nbsp;</TD><TD width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>25,545&nbsp;</P>
</TD><TD width=12>&nbsp;</TD><TD width=78><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>55,322</P>
</TD><TD width=12.4>&nbsp;</TD><TD width=71.267><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>49,878&nbsp;</P>
</TD></TR>
<TR><TD width=320.8><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt">Purchased in-process research and development expense</P>
</TD><TD width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>--&nbsp;</P>
</TD><TD width=12>&nbsp;</TD><TD width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>--&nbsp;</P>
</TD><TD width=12>&nbsp;</TD><TD width=78><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>--&nbsp;</P>
</TD><TD width=12.4>&nbsp;</TD><TD width=71.267><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>900&nbsp;</P>
</TD></TR>
<TR><TD width=320.8><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt">Interest expense</P>
</TD><TD width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>8,044&nbsp;</P>
</TD><TD width=12>&nbsp;</TD><TD width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>4,919&nbsp;</P>
</TD><TD width=12>&nbsp;</TD><TD width=78><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>16,161</P>
</TD><TD width=12.4>&nbsp;</TD><TD width=71.267><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>9,969&nbsp;</P>
</TD></TR>
<TR><TD width=320.8><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt">Foreign exchange (gains) losses, net</P>
</TD><TD width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>(922)</P>
</TD><TD width=12>&nbsp;</TD><TD width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>545&nbsp;</P>
</TD><TD width=12>&nbsp;</TD><TD width=78><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>(1,199)</P>
</TD><TD width=12.4>&nbsp;</TD><TD width=71.267><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>747&nbsp;</P>
</TD></TR>
<TR><TD width=320.8><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt">Other (income) expense, net</P>
</TD><TD style="border-bottom:0.5pt solid #000000" width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>(4,689)</P>
</TD><TD width=12>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>(866)</P>
</TD><TD width=12>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" width=78><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>(10,527)</P>
</TD><TD width=12.4>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" width=71.267><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>(650)</P>
</TD></TR>
<TR><TD width=320.8><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt">Income from continuing operations before taxes</P>
</TD><TD width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>25,489&nbsp;</P>
</TD><TD width=12>&nbsp;</TD><TD width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>29,319&nbsp;</P>
</TD><TD width=12>&nbsp;</TD><TD width=78><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>63,572</P>
</TD><TD width=12.4>&nbsp;</TD><TD width=71.267><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>60,825&nbsp;</P>
</TD></TR>
<TR><TD width=320.8><P style="margin:0pt; text-indent:14.4pt; line-height:11pt; font-family:Arial; font-size:9pt">Provision for income taxes</P>
</TD><TD style="border-bottom:0.5pt solid #000000" width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>7,101&nbsp;</P>
</TD><TD width=12>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>9,048&nbsp;</P>
</TD><TD width=12>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" width=78><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>15,664</P>
</TD><TD width=12.4>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" width=71.267><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>17,934&nbsp;</P>
</TD></TR>
<TR><TD width=320.8><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt">Income from continuing operations</P>
</TD><TD style="border-bottom:0.5pt solid #000000" width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>18,388&nbsp;</P>
</TD><TD width=12>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>20,271&nbsp;</P>
</TD><TD width=12>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" width=78><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>47,908</P>
</TD><TD width=12.4>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" width=71.267><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>42,891&nbsp;</P>
</TD></TR>
<TR><TD width=320.8><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt">Discontinued operations</P>
</TD><TD width=72>&nbsp;</TD><TD width=12>&nbsp;</TD><TD width=72>&nbsp;</TD><TD width=12>&nbsp;</TD><TD width=78>&nbsp;</TD><TD width=12.4>&nbsp;</TD><TD width=71.267>&nbsp;</TD></TR>
<TR><TD width=320.8><P style="margin:0pt; text-indent:14.4pt; line-height:11pt; font-family:Arial; font-size:9pt">Discontinued operations (net of tax)</P>
</TD><TD width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>--&nbsp;</P>
</TD><TD width=12>&nbsp;</TD><TD width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>(845)</P>
</TD><TD width=12>&nbsp;</TD><TD width=78><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>--&nbsp;</P>
</TD><TD width=12.4>&nbsp;</TD><TD width=71.267><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>(1,487)</P>
</TD></TR>
<TR><TD width=320.8><P style="margin:0pt; text-indent:14.4pt; line-height:11pt; font-family:Arial; font-size:9pt">Gain on divestiture (net of tax)</P>
</TD><TD style="border-bottom:0.5pt solid #000000" width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>--&nbsp;</P>
</TD><TD width=12>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>3,437&nbsp;</P>
</TD><TD width=12>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" width=78><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>3,974</P>
</TD><TD width=12.4>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" width=71.267><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>&nbsp;3,437&nbsp;</P>
</TD></TR>
<TR><TD width=320.8><P style="margin:0pt; text-indent:14.4pt; line-height:11pt; font-family:Arial; font-size:9pt">Total discontinued operations</P>
</TD><TD style="border-bottom:0.5pt solid #000000" width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>--&nbsp;</P>
</TD><TD width=12>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>2,592&nbsp;</P>
</TD><TD width=12>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" width=78><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>3,974</P>
</TD><TD width=12.4>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" width=71.267><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>1,950&nbsp;</P>
</TD></TR>
<TR><TD width=320.8><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt">Net income</P>
</TD><TD style="border-bottom:2pt double #000000" width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;18,388&nbsp;</P>
</TD><TD width=12>&nbsp;</TD><TD style="border-bottom:2pt double #000000" width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>$ &nbsp;&nbsp;&nbsp;22,863&nbsp;</P>
</TD><TD width=12>&nbsp;</TD><TD style="border-bottom:2pt double #000000" width=78><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;51,882</P>
</TD><TD width=12.4>&nbsp;</TD><TD style="border-bottom:2pt double #000000" width=71.267><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>$ &nbsp;&nbsp;44,841&nbsp;</P>
</TD></TR>
<TR><TD width=320.8>&nbsp;</TD><TD width=72>&nbsp;</TD><TD width=12>&nbsp;</TD><TD width=72>&nbsp;</TD><TD width=12>&nbsp;</TD><TD width=78>&nbsp;</TD><TD width=12.4>&nbsp;</TD><TD width=71.267>&nbsp;</TD></TR>
<TR><TD width=320.8><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt">Basic earnings per share:</P>
</TD><TD width=72>&nbsp;</TD><TD width=12>&nbsp;</TD><TD width=72>&nbsp;</TD><TD width=12>&nbsp;</TD><TD width=78>&nbsp;</TD><TD width=12.4>&nbsp;</TD><TD width=71.267>&nbsp;</TD></TR>
<TR><TD width=320.8><P style="margin:0pt; text-indent:14.4pt; line-height:11pt; font-family:Arial; font-size:9pt">Continuing operations</P>
</TD><TD width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>$ &nbsp;&nbsp;0.71&nbsp;</P>
</TD><TD width=12>&nbsp;</TD><TD width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>$ &nbsp;&nbsp;0.79&nbsp;</P>
</TD><TD width=12>&nbsp;</TD><TD width=78><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>$ &nbsp;&nbsp;1.85&nbsp;</P>
</TD><TD width=12.4>&nbsp;</TD><TD width=71.267><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>$ &nbsp;&nbsp;1.67&nbsp;</P>
</TD></TR>
<TR><TD width=320.8><P style="margin:0pt; text-indent:14.4pt; line-height:11pt; font-family:Arial; font-size:9pt">Discontinued operations</P>
</TD><TD style="border-bottom:0.5pt solid #000000" width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>--&nbsp;</P>
</TD><TD width=12>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>0.10&nbsp;</P>
</TD><TD width=12>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" width=78><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>0.15&nbsp;</P>
</TD><TD width=12.4>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" width=71.267><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>0.08&nbsp;</P>
</TD></TR>
<TR><TD width=320.8><P style="margin:0pt; text-indent:14.4pt; line-height:11pt; font-family:Arial; font-size:9pt">Net income</P>
</TD><TD style="border-bottom:2pt double #000000" width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>$ &nbsp;&nbsp;0.71&nbsp;</P>
</TD><TD width=12>&nbsp;</TD><TD style="border-bottom:2pt double #000000" width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>$ &nbsp;&nbsp;0.89&nbsp;</P>
</TD><TD width=12>&nbsp;</TD><TD style="border-bottom:2pt double #000000" width=78><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>$ &nbsp;&nbsp;2.00&nbsp;</P>
</TD><TD width=12.4>&nbsp;</TD><TD style="border-bottom:2pt double #000000" width=71.267><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>$ &nbsp;&nbsp;1.75&nbsp;</P>
</TD></TR>
<TR><TD width=320.8>&nbsp;</TD><TD width=72>&nbsp;</TD><TD width=12>&nbsp;</TD><TD width=72>&nbsp;</TD><TD width=12>&nbsp;</TD><TD width=78>&nbsp;</TD><TD width=12.4>&nbsp;</TD><TD width=71.267>&nbsp;</TD></TR>
<TR><TD width=320.8><P style="margin:0pt; text-indent:14.4pt; line-height:11pt; font-family:Arial; font-size:9pt">Weighted average common shares</P>
</TD><TD style="border-bottom:2pt double #000000" width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>26,020&nbsp;</P>
</TD><TD width=12>&nbsp;</TD><TD style="border-bottom:2pt double #000000" width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>25,699&nbsp;</P>
</TD><TD width=12>&nbsp;</TD><TD style="border-bottom:2pt double #000000" width=78><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>25,965&nbsp;</P>
</TD><TD width=12.4>&nbsp;</TD><TD style="border-bottom:2pt double #000000" width=71.267><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>25,662&nbsp;</P>
</TD></TR>
<TR><TD width=320.8>&nbsp;</TD><TD width=72>&nbsp;</TD><TD width=12>&nbsp;</TD><TD width=72>&nbsp;</TD><TD width=12>&nbsp;</TD><TD width=78>&nbsp;</TD><TD width=12.4>&nbsp;</TD><TD width=71.267>&nbsp;</TD></TR>
<TR><TD width=320.8><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt">Diluted earnings per share:</P>
</TD><TD width=72>&nbsp;</TD><TD width=12>&nbsp;</TD><TD width=72>&nbsp;</TD><TD width=12>&nbsp;</TD><TD width=78>&nbsp;</TD><TD width=12.4>&nbsp;</TD><TD width=71.267>&nbsp;</TD></TR>
<TR><TD width=320.8><P style="margin:0pt; text-indent:14.4pt; line-height:11pt; font-family:Arial; font-size:9pt">Continuing operations</P>
</TD><TD width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>$ &nbsp;&nbsp;0.69&nbsp;</P>
</TD><TD width=12>&nbsp;</TD><TD width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>$ &nbsp;&nbsp;0.76&nbsp;</P>
</TD><TD width=12>&nbsp;</TD><TD width=78><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>$ &nbsp;&nbsp;1.80&nbsp;</P>
</TD><TD width=12.4>&nbsp;</TD><TD width=71.267><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>$ &nbsp;&nbsp;1.62&nbsp;</P>
</TD></TR>
<TR><TD width=320.8><P style="margin:0pt; text-indent:14.4pt; line-height:11pt; font-family:Arial; font-size:9pt">Discontinued operations</P>
</TD><TD style="border-bottom:0.5pt solid #000000" width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>--&nbsp;</P>
</TD><TD width=12>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>0.10&nbsp;</P>
</TD><TD width=12>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" width=78><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>0.15&nbsp;</P>
</TD><TD width=12.4>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" width=71.267><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>0.07&nbsp;</P>
</TD></TR>
<TR><TD width=320.8><P style="margin:0pt; text-indent:14.4pt; line-height:11pt; font-family:Arial; font-size:9pt">Net income</P>
</TD><TD style="border-bottom:2pt double #000000" width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>$ &nbsp;&nbsp;0.69&nbsp;</P>
</TD><TD width=12>&nbsp;</TD><TD style="border-bottom:2pt double #000000" width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>$ &nbsp;&nbsp;0.86&nbsp;</P>
</TD><TD width=12>&nbsp;</TD><TD style="border-bottom:2pt double #000000" width=78><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>$ &nbsp;&nbsp;1.95&nbsp;</P>
</TD><TD width=12.4>&nbsp;</TD><TD style="border-bottom:2pt double #000000" width=71.267><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>$ &nbsp;&nbsp;1.69&nbsp;</P>
</TD></TR>
<TR><TD width=320.8>&nbsp;</TD><TD width=72>&nbsp;</TD><TD width=12>&nbsp;</TD><TD width=72>&nbsp;</TD><TD width=12>&nbsp;</TD><TD width=78>&nbsp;</TD><TD width=12.4>&nbsp;</TD><TD width=71.267>&nbsp;</TD></TR>
<TR><TD width=320.8><P style="margin:0pt; text-indent:14.4pt; line-height:11pt; font-family:Arial; font-size:9pt">Weighted average common shares</P>
</TD><TD style="border-bottom:2pt double #000000" width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>26,610</P>
</TD><TD width=12>&nbsp;</TD><TD style="border-bottom:2pt double #000000" width=72><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>26,504&nbsp;</P>
</TD><TD width=12>&nbsp;</TD><TD style="border-bottom:2pt double #000000" width=78><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>26,583</P>
</TD><TD width=12.4>&nbsp;</TD><TD style="border-bottom:2pt double #000000" width=71.267><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>26,474&nbsp;</P>
</TD></TR>
<TR><TD width=320.8>&nbsp;</TD><TD width=72>&nbsp;</TD><TD width=12>&nbsp;</TD><TD width=72>&nbsp;</TD><TD width=12>&nbsp;</TD><TD width=78>&nbsp;</TD><TD width=12.4>&nbsp;</TD><TD width=71.267>&nbsp;</TD></TR>
<TR><TD width=320.8>&nbsp;</TD><TD width=72>&nbsp;</TD><TD width=12>&nbsp;</TD><TD width=72>&nbsp;</TD><TD width=12>&nbsp;</TD><TD width=78>&nbsp;</TD><TD width=12.4>&nbsp;</TD><TD width=71.267>&nbsp;</TD></TR>
<TR><TD width=650.467 colspan=8>&nbsp;</TD></TR>
</TABLE>
<P style="margin:0pt; font-family:Courier New; font-size:12pt"><BR>
<BR></P>
<P style="page-break-before:always; margin:0pt; font-family:Arial; font-size:11pt"><BR></P>
<TABLE style="font-size:10pt" cellspacing=0><TR><TD valign=top width=607.2 colspan=5><P style="margin:0pt; font-family:Arial" align=center>BIO-RAD LABORATORIES, INC</P>
</TD></TR>
<TR><TD valign=top width=607.2 colspan=5><P style="margin:0pt; font-family:Arial" align=center>Condensed Consolidated Balance Sheets</P>
</TD></TR>
<TR><TD valign=top width=607.2 colspan=5><P style="margin:0pt; font-family:Arial" align=center>(In thousands)</P>
</TD></TR>
<TR><TD valign=top width=607.2 colspan=5><P style="margin:0pt; font-family:Arial" align=center>&nbsp;(Unaudited)</P>
</TD></TR>
<TR><TD valign=top width=403.2>&nbsp;</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=80.267>&nbsp;</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=92.267>&nbsp;</TD></TR>
<TR><TD valign=top width=403.2>&nbsp;</TD><TD valign=top width=15.733>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" valign=top width=80.267><P style="margin:0pt; font-family:Arial; font-size:9pt" align=center>June 30, </P>
<P style="margin:0pt; font-family:Arial; font-size:9pt" align=center>2005</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" valign=top width=92.267><P style="margin:0pt; font-family:Arial; font-size:9pt" align=center>December 31, 2004</P>
</TD></TR>
<TR><TD valign=top width=403.2>&nbsp;</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=80.267>&nbsp;</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=92.267>&nbsp;</TD></TR>
<TR><TD valign=top width=403.2><P style="margin:0pt; font-family:Arial; font-size:9pt">Current Assets:</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=80.267>&nbsp;</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=92.267>&nbsp;</TD></TR>
<TR><TD valign=top width=403.2><P style="margin:0pt; text-indent:14.4pt; font-family:Arial; font-size:9pt">Cash and cash equivalents </P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD width=80.267><P style="margin:0pt; line-height:9pt; font-family:Arial; font-size:9pt" align=right>$ &nbsp;&nbsp;252,132&nbsp;</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=92.267><P style="margin:0pt; font-family:Arial; font-size:9pt" align=right>$ &nbsp;&nbsp;195,734&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=403.2><P style="margin:0pt; text-indent:14.4pt; font-family:Arial; font-size:9pt">Restricted cash</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD width=80.267><P style="margin:0pt; line-height:9pt; font-family:Arial; font-size:9pt" align=right>35,565&nbsp;</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=92.267><P style="margin:0pt; font-family:Arial; font-size:9pt" align=right>--&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=403.2><P style="margin:0pt; text-indent:14.4pt; font-family:Arial; font-size:9pt">Short-term investments</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD width=80.267><P style="margin:0pt; line-height:9pt; font-family:Arial; font-size:9pt" align=right>91,252&nbsp;</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=92.267><P style="margin:0pt; font-family:Arial; font-size:9pt" align=right>165,899&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=403.2><P style="margin:0pt; text-indent:14.4pt; font-family:Arial; font-size:9pt">Accounts receivable, net </P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD width=80.267><P style="margin:0pt; line-height:9pt; font-family:Arial; font-size:9pt" align=right>243,387&nbsp;</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=92.267><P style="margin:0pt; font-family:Arial; font-size:9pt" align=right>261,243&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=403.2><P style="margin:0pt; text-indent:14.4pt; line-height:11pt; font-family:Arial; font-size:9pt">Inventories, net </P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD width=80.267><P style="margin:0pt; line-height:9pt; font-family:Arial; font-size:9pt" align=right>211,526&nbsp;</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=92.267><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>205,512&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=403.2><P style="margin:0pt; text-indent:14.4pt; font-family:Arial; font-size:9pt">Prepaid expenses, taxes and other current assets</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" width=80.267><P style="margin:0pt; line-height:9pt; font-family:Arial; font-size:9pt" align=right>83,496&nbsp;</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" valign=top width=92.267><P style="margin:0pt; font-family:Arial; font-size:9pt" align=right>80,072&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=403.2><P style="margin:0pt; text-indent:21.6pt; font-family:Arial; font-size:9pt">Total current assets </P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD width=80.267><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>917,358&nbsp;</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=92.267><P style="margin:0pt; font-family:Arial; font-size:9pt" align=right>908,460&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=403.2>&nbsp;</TD><TD valign=top width=15.733>&nbsp;</TD><TD width=80.267>&nbsp;</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=92.267>&nbsp;</TD></TR>
<TR><TD valign=top width=403.2><P style="margin:0pt; font-family:Arial; font-size:9pt">Net property, plant and equipment </P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD width=80.267><P style="margin:0pt; line-height:9pt; font-family:Arial; font-size:9pt" align=right>189,802&nbsp;</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=92.267><P style="margin:0pt; font-family:Arial; font-size:9pt" align=right>202,324&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=403.2><P style="margin:0pt; font-family:Arial; font-size:9pt">Goodwill </P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD width=80.267><P style="margin:0pt; line-height:9pt; font-family:Arial; font-size:9pt" align=right>113,276&nbsp;</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=92.267><P style="margin:0pt; font-family:Arial; font-size:9pt" align=right>113,276&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=403.2><P style="margin:0pt; font-family:Arial; font-size:9pt">Purchased intangibles, net</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD width=80.267><P style="margin:0pt; line-height:9pt; font-family:Arial; font-size:9pt" align=right>53,260&nbsp;</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=92.267><P style="margin:0pt; font-family:Arial; font-size:9pt" align=right>58,638&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=403.2><P style="margin:0pt; font-family:Arial; font-size:9pt">Other assets </P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" width=80.267><P style="margin:0pt; line-height:9pt; font-family:Arial; font-size:9pt" align=right>118,879&nbsp;</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" valign=top width=92.267><P style="margin:0pt; font-family:Arial; font-size:9pt" align=right>109,304&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=403.2><P style="margin:0pt; text-indent:21.6pt; font-family:Arial; font-size:9pt">Total assets</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD style="border-bottom:2pt double #000000" width=80.267><P style="margin:0pt; font-family:Arial; font-size:9pt" align=right>$ 1,392,575&nbsp;</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD style="border-bottom:2pt double #000000" valign=top width=92.267><P style="margin:0pt; font-family:Arial; font-size:9pt" align=right>$ 1,392,002&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=403.2>&nbsp;</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=80.267>&nbsp;</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=92.267>&nbsp;</TD></TR>
<TR><TD valign=top width=403.2><P style="margin:0pt; font-family:Arial; font-size:9pt">Current liabilities:</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=80.267>&nbsp;</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=92.267>&nbsp;</TD></TR>
<TR><TD valign=top width=403.2><P style="margin:0pt; text-indent:14.4pt; font-family:Arial; font-size:9pt">Notes payable and current maturities of long-term debt</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=80.267><P style="margin:0pt; font-family:Arial; font-size:9pt" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11,479</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=92.267><P style="margin:0pt; font-family:Arial; font-size:9pt" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9,457&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=403.2><P style="margin:0pt; text-indent:14.4pt; font-family:Arial; font-size:9pt">Accounts payable</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=80.267><P style="margin:0pt; font-family:Arial; font-size:9pt" align=right>69,254</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=92.267><P style="margin:0pt; font-family:Arial; font-size:9pt" align=right>71,194&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=403.2><P style="margin:0pt; text-indent:14.4pt; font-family:Arial; font-size:9pt">Accrued payroll and employee benefits</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD width=80.267><P style="margin:0pt; line-height:9pt; font-family:Arial; font-size:9pt" align=right>67,926</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=92.267><P style="margin:0pt; font-family:Arial; font-size:9pt" align=right>79,061&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=403.2><P style="margin:0pt; text-indent:14.4pt; font-family:Arial; font-size:9pt">Sales, income and other taxes payable</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD width=80.267><P style="margin:0pt; line-height:9pt; font-family:Arial; font-size:9pt" align=right>11,549</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=92.267><P style="margin:0pt; font-family:Arial; font-size:9pt" align=right>15,835&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=403.2><P style="margin:0pt; text-indent:14.4pt; font-family:Arial; font-size:9pt">Other current liabilities</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" width=80.267><P style="margin:0pt; line-height:9pt; font-family:Arial; font-size:9pt" align=right>130,640</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" valign=top width=92.267><P style="margin:0pt; font-family:Arial; font-size:9pt" align=right>139,828&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=403.2><P style="margin:0pt; text-indent:21.6pt; font-family:Arial; font-size:9pt">Total current liabilities</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD width=80.267><P style="margin:0pt; font-family:Arial; font-size:9pt" align=right>290,848</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=92.267><P style="margin:0pt; font-family:Arial; font-size:9pt" align=right>315,375&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=403.2>&nbsp;</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=80.267>&nbsp;</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=92.267>&nbsp;</TD></TR>
<TR><TD valign=top width=403.2><P style="margin:0pt; font-family:Arial; font-size:9pt">Long-term debt, net of current maturities</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD width=80.267><P style="margin:0pt; line-height:9pt; font-family:Arial; font-size:9pt" align=right>425,864</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=92.267><P style="margin:0pt; font-family:Arial; font-size:9pt" align=right>425,979&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=403.2><P style="margin:0pt; font-family:Arial; font-size:9pt">Deferred tax liabilities</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD width=80.267><P style="margin:0pt; line-height:9pt; font-family:Arial; font-size:9pt" align=right>27,011</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=92.267><P style="margin:0pt; font-family:Arial; font-size:9pt" align=right>24,772&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=403.2><P style="margin:0pt; font-family:Arial; font-size:9pt">Other long-term liabilities</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD width=80.267><P style="margin:0pt; line-height:9pt; font-family:Arial; font-size:9pt" align=right>20,208</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=92.267><P style="margin:0pt; font-family:Arial; font-size:9pt" align=right>28,988&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=403.2><P style="margin:0pt; font-family:Arial; font-size:9pt">Stockholders&#146; equity</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" width=80.267><P style="margin:0pt; line-height:10pt; font-family:Arial; font-size:9pt" align=right>628,644</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" valign=top width=92.267><P style="margin:0pt; font-family:Arial; font-size:9pt" align=right>596,888&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=403.2><P style="margin:0pt; text-indent:21.6pt; font-family:Arial; font-size:9pt">Total liabilities and stockholders&#146; equity </P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD style="border-bottom:2pt double #000000" width=80.267><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>$ 1,392,575</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD style="border-bottom:2pt double #000000" valign=top width=92.267><P style="margin:0pt; font-family:Arial; font-size:9pt" align=right>$ 1,392,002&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=403.2>&nbsp;</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=80.267>&nbsp;</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=92.267>&nbsp;</TD></TR>
<TR><TD valign=top width=607.2 colspan=5><P style="margin:0pt; font-family:Arial; font-size:9pt">&nbsp;<I>Certain items have been reclassified to conform to the current year presentation.</I></P>
</TD></TR>
</TABLE>
<P style="margin:0pt; font-family:Courier New; font-size:12pt"><BR></P>
<P style="margin:0pt; font-family:Courier New; font-size:12pt" align=center><BR>
<BR></P>
<P style="page-break-before:always; margin:0pt; font-family:Arial" align=center><BR></P>
<TABLE style="font-size:10pt" cellspacing=0><TR><TD valign=top width=595.2 colspan=5><P style="margin:0pt; font-family:Arial" align=center>BIO-RAD LABORATORIES, INC.</P>
</TD></TR>
<TR><TD valign=top width=595.2 colspan=5><P style="margin:0pt; font-family:Arial" align=center>Condensed Consolidated Statements of Cash Flows</P>
</TD></TR>
<TR><TD valign=top width=595.2 colspan=5><P style="margin:0pt; font-family:Arial" align=center>(in thousands)</P>
</TD></TR>
<TR><TD valign=top width=595.2 colspan=5><P style="margin:0pt; font-family:Arial" align=center>(Unaudited)</P>
</TD></TR>
<TR><TD valign=top width=427.2>&nbsp;</TD><TD valign=top width=78.533>&nbsp;</TD><TD valign=top width=17.467 colspan=2>&nbsp;</TD><TD valign=top width=72>&nbsp;</TD></TR>
<TR><TD valign=top width=427.2>&nbsp;</TD><TD valign=top width=168 colspan=4><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=center>Six Months Ended</P>
</TD></TR>
<TR><TD valign=top width=427.2>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" valign=top width=168 colspan=4><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=center>June 30,</P>
</TD></TR>
<TR><TD valign=top width=427.2>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" valign=top width=78.533><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=center>2005</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" valign=top width=73.733 colspan=2><P style="margin:0pt; line-height:11pt; font-family:Arial; font-size:9pt" align=center>2004</P>
</TD></TR>
<TR><TD valign=top width=427.2><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt">Cash flows from operating activities:</P>
</TD><TD valign=top width=78.533>&nbsp;</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=73.733 colspan=2>&nbsp;</TD></TR>
<TR><TD valign=top width=427.2><P style="margin-top:0pt; margin-bottom:0.75pt; text-indent:7.2pt; line-height:11pt; font-family:Arial; font-size:9pt">Cash received from customers</P>
</TD><TD valign=top width=78.533><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>$ 583,459&nbsp;</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=73.733 colspan=2><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>$ 517,385&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=427.2><P style="margin-top:0pt; margin-bottom:0.75pt; text-indent:7.2pt; line-height:11pt; font-family:Arial; font-size:9pt">Cash paid to suppliers and employees</P>
</TD><TD valign=top width=78.533><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>(527,665)</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=73.733 colspan=2><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>(440,664)</P>
</TD></TR>
<TR><TD valign=top width=427.2><P style="margin-top:0pt; margin-bottom:0.75pt; text-indent:7.2pt; line-height:11pt; font-family:Arial; font-size:9pt">Interest paid</P>
</TD><TD valign=top width=78.533><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>(15,459)</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=73.733 colspan=2><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>(9,866)</P>
</TD></TR>
<TR><TD valign=top width=427.2><P style="margin-top:0pt; margin-bottom:0.75pt; text-indent:7.2pt; line-height:11pt; font-family:Arial; font-size:9pt">Income tax payments</P>
</TD><TD valign=top width=78.533><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>(20,161)</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=73.733 colspan=2><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>(20,860)</P>
</TD></TR>
<TR><TD valign=top width=427.2><P style="margin-top:0pt; margin-bottom:0.75pt; text-indent:7.2pt; line-height:11pt; font-family:Arial; font-size:9pt">Miscellaneous receipts</P>
</TD><TD valign=top width=78.533><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>8,971&nbsp;</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=73.733 colspan=2><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>3,568&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=427.2><P style="margin-top:0pt; margin-bottom:0.75pt; text-indent:7.2pt; line-height:11pt; font-family:Arial; font-size:9pt">Discontinued operations</P>
</TD><TD style="border-bottom:0.5pt solid #000000" valign=top width=78.533><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>(1,327)</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" valign=top width=73.733 colspan=2><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>(2,019)</P>
</TD></TR>
<TR><TD valign=top width=427.2><P style="margin-top:0pt; margin-bottom:0.75pt; text-indent:7.2pt; line-height:11pt; font-family:Arial; font-size:9pt">Net cash provided by operating activities</P>
</TD><TD valign=top width=78.533><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>27,818&nbsp;</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=73.733 colspan=2><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>47,544&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=427.2>&nbsp;</TD><TD valign=top width=78.533>&nbsp;</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=73.733 colspan=2>&nbsp;</TD></TR>
<TR><TD valign=top width=427.2><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt">Cash flows from investing activities:</P>
</TD><TD valign=top width=78.533>&nbsp;</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=73.733 colspan=2>&nbsp;</TD></TR>
<TR><TD valign=top width=427.2><P style="margin-top:0pt; margin-bottom:0.75pt; text-indent:7.2pt; line-height:11pt; font-family:Arial; font-size:9pt">Capital expenditures, net</P>
</TD><TD valign=top width=78.533><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>(17,591)</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=73.733 colspan=2><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>(29,057)</P>
</TD></TR>
<TR><TD valign=top width=427.2><P style="margin-top:0pt; margin-bottom:0.75pt; text-indent:7.2pt; line-height:11pt; font-family:Arial; font-size:9pt">Other investing activities</P>
</TD><TD style="border-bottom:0.5pt solid #000000" valign=top width=78.533><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>40,585&nbsp;</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" valign=top width=73.733 colspan=2><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>(55,181)</P>
</TD></TR>
<TR><TD valign=top width=427.2><P style="margin-top:0pt; margin-bottom:0.75pt; text-indent:7.2pt; line-height:11pt; font-family:Arial; font-size:9pt">Net cash provided by (used in) investing activities</P>
</TD><TD valign=top width=78.533><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>22,994&nbsp;</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=73.733 colspan=2><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>(84,238)</P>
</TD></TR>
<TR><TD valign=top width=427.2>&nbsp;</TD><TD valign=top width=78.533>&nbsp;</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=73.733 colspan=2>&nbsp;</TD></TR>
<TR><TD valign=top width=427.2><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt">Cash flows from financing activities:</P>
</TD><TD valign=top width=78.533>&nbsp;</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=73.733 colspan=2>&nbsp;</TD></TR>
<TR><TD valign=top width=427.2><P style="margin-top:0pt; margin-bottom:0.75pt; text-indent:7.2pt; line-height:11pt; font-family:Arial; font-size:9pt">Payments on long-term debt</P>
</TD><TD valign=top width=78.533><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>(231)</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=73.733 colspan=2><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>(212)</P>
</TD></TR>
<TR><TD valign=top width=427.2><P style="margin-top:0pt; margin-bottom:0.75pt; text-indent:7.2pt; line-height:11pt; font-family:Arial; font-size:9pt">Other financing activities</P>
</TD><TD style="border-bottom:0.5pt solid #000000" valign=top width=78.533><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>5,323&nbsp;</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" valign=top width=73.733 colspan=2><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>3,465&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=427.2><P style="margin-top:0pt; margin-bottom:0.75pt; text-indent:7.2pt; line-height:11pt; font-family:Arial; font-size:9pt">Net cash provided by financing activities</P>
</TD><TD valign=top width=78.533><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>5,092&nbsp;</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=73.733 colspan=2><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>3,253&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=427.2>&nbsp;</TD><TD valign=top width=78.533>&nbsp;</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=73.733 colspan=2>&nbsp;</TD></TR>
<TR><TD valign=top width=427.2><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt">Effect of exchange rate changes on cash </P>
</TD><TD style="border-bottom:0.5pt solid #000000" valign=top width=78.533><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>494&nbsp;</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" valign=top width=73.733 colspan=2><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>1,325&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=427.2>&nbsp;</TD><TD valign=top width=78.533>&nbsp;</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=73.733 colspan=2>&nbsp;</TD></TR>
<TR><TD valign=top width=427.2><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt">Net increase (decrease) in cash and cash equivalents</P>
</TD><TD valign=top width=78.533><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>56,398&nbsp;</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=73.733 colspan=2><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>(32,116)</P>
</TD></TR>
<TR><TD valign=top width=427.2><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt">Cash and cash equivalents at beginning of period</P>
</TD><TD style="border-bottom:0.5pt solid #000000" valign=top width=78.533><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>195,734&nbsp;</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" valign=top width=73.733 colspan=2><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>65,395&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=427.2><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt">Cash and cash equivalents at end of period</P>
</TD><TD style="border-bottom:2pt double #000000" valign=top width=78.533><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>$ 252,132&nbsp;</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD style="border-bottom:2pt double #000000" valign=top width=73.733 colspan=2><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>$ 33,279&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=427.2>&nbsp;</TD><TD valign=top width=78.533>&nbsp;</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=73.733 colspan=2>&nbsp;</TD></TR>
<TR><TD valign=top width=505.733 colspan=2><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt">Reconciliation of income from continuing operations to net cash provided by </P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=73.733 colspan=2>&nbsp;</TD></TR>
<TR><TD valign=top width=427.2><P style="margin-top:0pt; margin-bottom:0.75pt; text-indent:14.4pt; line-height:11pt; font-family:Arial; font-size:9pt">operating activities:</P>
</TD><TD valign=top width=78.533>&nbsp;</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=73.733 colspan=2>&nbsp;</TD></TR>
<TR><TD valign=top width=427.2><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt">Income from continuing operations</P>
</TD><TD valign=top width=78.533><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>$ 47,908&nbsp;</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=73.733 colspan=2><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>$ &nbsp;42,891&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=427.2><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt">Adjustments to reconcile net income to net cash provided by</P>
</TD><TD valign=top width=78.533>&nbsp;</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=73.733 colspan=2>&nbsp;</TD></TR>
<TR><TD valign=top width=427.2><P style="margin-top:0pt; margin-bottom:0.75pt; text-indent:7.2pt; line-height:11pt; font-family:Arial; font-size:9pt">operating activities (net of effects of acquisitions):</P>
</TD><TD valign=top width=78.533>&nbsp;</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=73.733 colspan=2>&nbsp;</TD></TR>
<TR><TD valign=top width=427.2><P style="margin-top:0pt; margin-bottom:0.75pt; text-indent:7.2pt; line-height:11pt; font-family:Arial; font-size:9pt">Depreciation and amortization</P>
</TD><TD valign=top width=78.533><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>30,091&nbsp;</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=73.733 colspan=2><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>22,881&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=427.2><P style="margin-top:0pt; margin-bottom:0.75pt; text-indent:7.2pt; line-height:11pt; font-family:Arial; font-size:9pt">Changes in working capital </P>
</TD><TD valign=top width=78.533><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>(45,925)</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=73.733 colspan=2><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>(19,540)</P>
</TD></TR>
<TR><TD valign=top width=427.2><P style="margin-top:0pt; margin-bottom:0.75pt; text-indent:7.2pt; line-height:11pt; font-family:Arial; font-size:9pt">Other</P>
</TD><TD valign=top width=78.533><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>(8,230)</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=73.733 colspan=2><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>2,799&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=427.2><P style="margin-top:0pt; margin-bottom:0.75pt; text-indent:7.2pt; line-height:11pt; font-family:Arial; font-size:9pt">Discontinued operations</P>
</TD><TD style="border-bottom:0.5pt solid #000000" valign=top width=78.533><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>3,974&nbsp;</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD style="border-bottom:0.5pt solid #000000" valign=top width=73.733 colspan=2><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>(1,487)</P>
</TD></TR>
<TR><TD valign=top width=427.2><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt">Net cash provided by operating activities</P>
</TD><TD style="border-bottom:2pt double #000000" valign=top width=78.533><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>$ &nbsp;27,818&nbsp;</P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD style="border-bottom:2pt double #000000" valign=top width=73.733 colspan=2><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt" align=right>$ &nbsp;47,544&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=427.2>&nbsp;</TD><TD valign=top width=78.533>&nbsp;</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=73.733 colspan=2>&nbsp;</TD></TR>
<TR><TD valign=top width=505.733 colspan=2><P style="margin-top:0pt; margin-bottom:0.75pt; line-height:11pt; font-family:Arial; font-size:9pt"><I>Certain items have been reclassified to conform to the current year presentation.</I></P>
</TD><TD valign=top width=15.733>&nbsp;</TD><TD valign=top width=73.733 colspan=2>&nbsp;</TD></TR>
</TABLE>
<P style="margin:0pt; font-family:Courier New; font-size:12pt"><BR></P>
<P style="margin:0pt; font-family:Courier New; font-size:12pt"><BR></P>
<P style="margin:0pt; font-family:Courier New; font-size:12pt"><BR>
<BR></P>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
